SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
295.80    10.40 (3.64%)
Bid:
296.80
Ask:
297.40
Spread: 0.60 (0.202%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Publication of Scheme Document

29 Mar 2023 07:00

RNS Number : 5417U
Breedon Group PLC
29 March 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION.

 

29 March 2023

 

BREEDON GROUP PLC

 

Scheme of Arrangement to introduce a new holding company incorporated in England and Wales

 

Publication of Scheme Document and notice of Jersey Court Meeting and Scheme General Meeting

 

 

On 8 March 2023, Breedon Group plc (the "Company" and together with its subsidiaries, "Breedon" or the "Group") announced its intention to move its listing from AIM to the premium listing segment of the Official List and to trading on the Main Market of the London Stock Exchange ("Admission").

 

In connection with Admission, the Company is proposing to undertake a corporate reorganisation by which a new holding company of the Group, incorporated in England and Wales ("New Breedon"), would be introduced by way of a scheme of arrangement (the "Scheme"). As part of the Scheme, Breedon intends to reduce the number of ordinary shares in issue by issuing 1 New Breedon Share for every 5 ordinary shares of the Company.

 

The Breedon Board is pleased to announce that it expects to publish a circular later today in relation to the Scheme (the "Scheme Document") setting out, amongst other things, a letter from the Chairman of Breedon, a summary of the transaction, the full terms and conditions of the Scheme, an expected timetable of principal events, notices of the Court Meeting and General Meeting and details of the actions to be taken by Breedon Shareholders, together with Forms of Proxy for the Court Meeting and the General Meeting. A copy of the Scheme Document will be made available on Breedon's website (www.breedongroup.com/aim-to-main).

 

Hard copies of the Scheme Document (or, depending on Breedon Shareholders' communication preferences, a letter or email giving details of the website where the Scheme Document may be accessed), and Forms of Proxy for the Court Meeting and the General Meeting are being sent to Breedon Shareholders today. Hard copies can also be requested by contacting Breedon's Registrars - for more details please see the Scheme Document.

 

New Breedon will also publish a prospectus (the "Prospectus") in connection with Admission in due course. Copies of this announcement will also be made available (subject to certain restrictions relating to persons in restricted jurisdictions) on Breedon's website at www.breedongroup.com/aim-to-main.

 

Reasons for the Scheme

 

For legal and commercial reasons, and in common with many listings on the Main Market, New Breedon will be used as the vehicle in which the Main Market listing takes place. Breedon's current status as a non-English company means it incurs duplicated costs in Jersey to order to comply with local corporate requirements. Accordingly, the Breedon Board, after detailed consideration, believes the proposed new corporate structure is the most appropriate structure for the Group and, together with the move to the Main Market, would best support its long term strategy and growth prospects. The introduction of New Breedon as the new ultimate holding company of the Group will be implemented by way of the Scheme.

 

Timetable

 

The expected timetable of events for the implementation of the Scheme is set out in the Scheme Document and is included in the Appendix to this announcement. The dates and times given are indicative only and are based on Breedon's current expectations and may be subject to change. If any of the dates and/or times set out in the expected timetable change, an announcement will be made through a Regulatory Information Service.

 

Conditions of the Scheme

 

In summary, the implementation of the Scheme is conditional on the following having occurred:

 

a) the Scheme being approved by a majority in number representing not less than 75 per cent. of the voting rights of the Scheme Shareholders present and voting (in person or by proxy) at the Jersey Court Meeting (or at any adjournment of that meeting);

b) the Special Resolution (as set out in the notice convening the Scheme General Meeting in Part 8 (Notice of Scheme General Meeting) of the Scheme Document) having been duly passed at the Scheme General Meeting by a majority of not less than two-thirds of the votes cast;

c) the Scheme having been sanctioned by the Court at the Sanction Hearing and the Court Order having been delivered to the Jersey Registrar of Companies and registered by it;

d) the FCA having acknowledged to New Breedon that the application for the admission of the New Breedon Shares to listing on the premium listing segment of the Official List has been approved and the London Stock Exchange having acknowledged to New Breedon that the New Breedon Shares will be admitted to trading on the Main Market; and

e) Breedon not having withdrawn the Scheme, which it shall be entitled to do at any time, and for any reason, prior to the point at which the Court issues the Court Order.

 

Further details in relation to the terms and conditions for the Scheme are set out in Part 2 of the Scheme Document.

 

Recommendation

 

The Breedon Directors consider the Scheme to be in the best interests of the Breedon Shareholders taken as a whole. Accordingly, the Breedon Directors unanimously recommend that Scheme Shareholders vote in favour of the Scheme at the Jersey Court Meeting, and that Breedon Shareholders vote votes in favour of the Special Resolution at the Scheme General Meeting, as they intend to do in respect of their own holdings.

 

 

ENQUIRIES:

Breedon Group plc

+44 (0) 1332 694010

Rob Wood, Chief Executive Officer

James Brotherton, Chief Financial Officer

Louise Turner-Smith, Head of Investor Relations

+44 (0) 7860 911909

 

Moelis (Financial Adviser to Breedon)

+44 (0) 207 634 3500

Mark Aedy, Daniel Muldoon, Andrew Welby

 

Numis (Sponsor, NOMAD and joint broker)

+44 (0) 20 7260 1000

Ben Stoop, Oliver Hardy (NOMAD)

 

HSBC (Joint broker)

+44 (0) 20 7991 8888

Sam McLennan, Joe Weaving

 

MHP (Public relations adviser)

+44 (0) 20 3128 8193

Reg Hoare, Rachel Farrington, Charles Hirst

breedon@mhpgroup.com

 

About Breedon Group plc

Breedon Group plc, a leading vertically-integrated construction materials group in Great Britain and Ireland, delivers essential products to the construction sector. Breedon holds 1bn tonnes of mineral reserves and resources with long reserve life, supplying value-added products and services, including specialty materials, surfacing and highway maintenance operations, to a broad range of customers through its extensive local network of quarries, ready-mixed concrete and asphalt plants.

The Group's two well-invested cement plants are actively engaged in a number of carbon reduction practices, which include utilising alternative raw materials and lower carbon fuels. Breedon's 3,700 colleagues embody our commitment to 'Make a Material Difference' as the Group continues to execute its strategy to create sustainable value for all stakeholders, delivering growth through organic improvement and acquisition in the heavyside construction materials market.

Important information

Unless otherwise defined in this announcement, capitalised words and phrases used in this announcement shall have the same meanings as ascribed to them in the Scheme Document.

This announcement may include statements that are, or may be deemed to be, "forward-looking statements" (including words such as "believe""expect""estimate""intend""anticipate" and words of similar meaning). By their nature, forward-looking statements involve risk and uncertainty since they relate to future events and circumstances, and actual results may, and often do, differ materially from any forward-looking statements. Any forward-looking statements in this announcement reflect management's view with respect to future events as at the date of this announcement. Save as required by applicable law, the Company undertakes no obligation to publicly revise any forward-looking statements in this announcement, whether following any change in its expectations or to reflect events or circumstances after the date of this announcement.

This announcement does not constitute an offer to sell, or the solicitation of an offer to acquire or subscribe for, shares in the Company or New Breedon in any jurisdiction. The distribution of this announcement outside the UK may be restricted by law. No action has been taken by the Company or New Breedon that would permit possession of this announcement in any jurisdiction outside the UK where action for that purpose is required. Persons outside the UK who come into possession of this announcement should inform themselves about the distribution of this announcement in their particular jurisdiction.

This announcement is not an offer of securities for sale in the United States. The New Breedon Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act") or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. The New Breedon Shares issued pursuant to the Scheme are expected to be issued in reliance upon the exemption from the registration requirements of the US Securities Act provided by section 3(a)(10) thereof based on the Jersey Court's sanctioning of the Scheme. Scheme Shareholders who will be affiliates of New Breedon after the Effective Date will be subject to certain US transfer restrictions relating to the New Breedon Shares received pursuant to the Scheme.

The Scheme has not been and will not be approved or disapproved by the Securities and Exchange Commission, any state's securities commission in the United States or any US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits or the fairness of the Scheme nor upon the accuracy or adequacy of the Scheme Document or the Prospectus. Any representation to the contrary is a criminal offence in the United States.

Numis Securities Limited ("Numis"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company and New Breedon as Sponsor and no one else in connection with Admission and it will not regard any other person as a client in relation to Admission and will not be responsible to anyone other than the Company and New Breedon for providing the protections afforded to its clients or for providing advice in relation to Admission or any other transaction, matter, or arrangement referred to in this announcement.

This announcement has been issued by, and is the sole responsibility of, the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by Numis or by any of its affiliates, directors, officers, employees, advisers or agents as to or in relation to, the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

 

APPENDIX - Expected Scheme timetable

 

 

Event

Time and/or date

Publication of the Scheme Document

29 March 2023

Latest time for lodging Forms of Proxy for the:

Jersey Court Meeting

2:15 p.m. on 24 April 2023

Scheme General Meeting

2:30 p.m. on 24 April 2023

Voting Record Time

6:30 p.m. on 24 April 2023

Jersey Court Meeting

 

2:15 p.m. on 26 April 2023

Scheme General Meeting

 

2:30 p.m. on 26 April 2023

 

The following dates are indicative only and are subject to change1

Expected date of publication of the Prospectus by New Breedon

11 May 2023

Sanction Hearing (to sanction the Scheme)

9.00 a.m. on 16 May 2023

Scheme Record Time

6.00 p.m. on 16 May 2023

Last day of dealings in, and for the registration of transfers of, and disablement in CREST of, Breedon Shares on AIM

16 May 2023

Effective Date

16 May 20232

Cancellation of admission to trading of Breedon Shares on AIM

by 7.00 a.m. on 17 May 2023

Admission of New Breedon Shares to listing on the premium listing segment of the Official List and to trading on the Main Market and commencement of dealings

8.00 a.m. on 17 May 2023

Crediting of New Breedon Shares to CREST accounts

8.00 a.m. on 17 May 2023

Share certificates for New Breedon Shares expected to be despatched within 10 Business Days of Admission

by 1 June 2023

Long Stop Date

 

30 June 20233

 

Notes

 

1. These dates are indicative only and will depend, among other things, on the date upon which: (i) the Conditions are satisfied or (if capable of waiver) waived; (ii) the Court sanctions the Scheme; and (iii) the Court Order is delivered to the Jersey Registrar of Companies. Participants in Breedon Share Plans will be contacted separately to inform them of the effect of the Scheme on their rights under Breedon Share Plans, including details of any appropriate proposals being made and dates and times relevant to them.

2. Following sanction of the Scheme by the Court, the Scheme will become Effective in accordance with its terms upon a copy of the Court Order being delivered to the Jersey Registrar of Companies. This is presently expected to occur on 16 May 2023, subject to satisfaction or (where capable of waiver), waiver of the Conditions.

3. This is the latest date by which the Scheme may become Effective. However, the Long Stop Date may be extended to such later date as Breedon and New Breedon may agree (and as the Court may allow, should such approval be required).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SOAPPUGPWUPWPUR
Date   Source Headline
10th Jul 20197:00 amRNSHolding(s) in Company
9th Jul 20192:57 pmRNSHolding(s) in Company
7th Jun 20194:44 pmRNSHolding(s) in Company
7th Jun 20199:00 amRNSHolding(s) in Company
4th Jun 20191:01 pmRNSDirector / PDMR Dealings & Total Voting Rights
29th May 201912:38 pmRNSFurther re: Intended Sale of Shares
29th May 20197:05 amRNSIntended Sale of Shares
29th May 20197:00 amRNSDirectorate Change
7th May 20195:05 pmRNSDirector / PDMR Dealings & Total Voting Rights
30th Apr 20192:39 pmRNSResult of AGM
30th Apr 20197:00 amRNSAGM Statement
16th Apr 201910:14 amRNSDirectors' and PDMRs' Dealings
8th Apr 20193:12 pmRNSDirector and PDMR Dealings & Issue of Equity
2nd Apr 201912:02 pmRNSDirector and PDMR Dealings and Issue of Equity
1st Apr 20195:00 pmRNSGrant of SAYE Options and PDMR Dealings
18th Mar 20199:23 amRNSDirector Dealings
6th Mar 20197:00 amRNSAnnual Results 2018
15th Feb 201910:53 amRNSHolding(s) in Company
23rd Jan 20192:30 pmRNSBlock listing Interim Review
18th Dec 201811:20 amRNSDirectorate Change
17th Dec 201810:20 amRNSDirector/PDMR Shareholding
14th Dec 20183:46 pmRNSDirector/PDMR Shareholding
12th Dec 20182:27 pmRNSDirector/PDMR Shareholding
7th Dec 20181:00 pmRNSDirector/PDMR Shareholding
6th Dec 20184:57 pmRNSDirector/PDMR Shareholding
27th Nov 201812:00 pmRNSTotal Voting Rights
21st Nov 20187:00 amRNSTrading Update
23rd Oct 20183:55 pmRNSDirector/PDMR Shareholding
17th Oct 20184:42 pmRNSDirector/PDMR Shareholding
16th Oct 20185:00 pmRNSGrant of SAYE Options and PDMR Dealings
12th Oct 201810:00 amRNSDirector/PDMR Shareholding
1st Oct 20188:05 amRNSAppointment of Non-Executive Director
25th Sep 20184:17 pmRNSDirector/PDMR Shareholding
14th Sep 20183:21 pmRNSHolding(s) in Company
14th Sep 20183:20 pmRNSHolding(s) in Company
5th Sep 20187:01 amRNSAppointment of Non-Executive Director
5th Sep 20187:00 amRNSHalf-year Report
1st Aug 20183:57 pmRNSHolding(s) in Company
25th Jul 20182:58 pmRNSHolding(s) in Company
25th Jul 20187:00 amRNSBlock Listing Update
2nd Jul 20187:00 amRNSBREEDON COMPLETES ASSET SWAP WITH TARMAC
1st Jun 20185:30 pmRNSDirector/PDMR Shareholding
1st Jun 20187:00 amRNSAcquisition of Blinkbonny Quarry
17th May 20184:55 pmRNSGrant of SAYE Options and PDMR Dealings
11th May 20183:30 pmRNSResults of Open Offer
8th May 201812:49 pmRNSDirector and PDMR Dealings
30th Apr 20184:19 pmRNSDirector/PDMR Shareholding
27th Apr 20182:18 pmRNSAdditional Block Listing of Ordinary Shares
26th Apr 20181:29 pmRNSDirector and PDMR Dealings and Issue of Equity
26th Apr 20188:00 amRNSCMA's Review of Proposed Acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.